What are the Steps for Treatment for Ovarian Cancer Stage 3?
Thank you.
Comments
-
Do you know where she is
Do you know where she is being treated? It is very common in late stage OC to do chemo prior to surgery. It often shrinks the tumor(s) and makes for a more successful de-bulking surgery. As far as I know, Hexamethylamine is most often used as a second-line treatment. Here is some info I found....
In the United States, the initial treatment of ovarian cancer is now in transition, with most patients receiving primary therapy with drugs that contain platinum and taxane compounds (e.g., cisplatin, carboplatin, paclitaxel); however, other drugs, such as "mustards" (e.g., melphalan) and anthracyclines (e.g., doxorubicin) also show first-line activity in ovarian cancer. The dose, timing, and choice of chemotherapies are determined by factors such as the patient's type and stage of ovarian cancer, her body's response to and recovery from chemotherapy, and her health status.
At the present time, only two drugs - hexamethylamine (Hexalen®, altretamine) and topotecan hydrochloride (Hycamtin™) - have been approved by the Food and Drug Administration (FDA) for use as second-line, or "salvage," agents in ovarian cancer (for example, metastatic ovarian cancer patients in whom initial or subsequent chemotherapy with paclitaxel and cisplatin has failed).0 -
Rachelle, I am so sorry toHissy_Fitz said:Do you know where she is
Do you know where she is being treated? It is very common in late stage OC to do chemo prior to surgery. It often shrinks the tumor(s) and makes for a more successful de-bulking surgery. As far as I know, Hexamethylamine is most often used as a second-line treatment. Here is some info I found....
In the United States, the initial treatment of ovarian cancer is now in transition, with most patients receiving primary therapy with drugs that contain platinum and taxane compounds (e.g., cisplatin, carboplatin, paclitaxel); however, other drugs, such as "mustards" (e.g., melphalan) and anthracyclines (e.g., doxorubicin) also show first-line activity in ovarian cancer. The dose, timing, and choice of chemotherapies are determined by factors such as the patient's type and stage of ovarian cancer, her body's response to and recovery from chemotherapy, and her health status.
At the present time, only two drugs - hexamethylamine (Hexalen®, altretamine) and topotecan hydrochloride (Hycamtin™) - have been approved by the Food and Drug Administration (FDA) for use as second-line, or "salvage," agents in ovarian cancer (for example, metastatic ovarian cancer patients in whom initial or subsequent chemotherapy with paclitaxel and cisplatin has failed).
Rachelle, I am so sorry to hear about your friend . . . I have been in treatment for a year with stage 4 clear cell. I had surgery first and I have tried two different "types" of chemo since. I will be starting a clinical trial tomorrow with Suniitinib Malate -- it has been approved by the FDA for a type of stomach and kidney cancer, but is being studied for the treatment of persistent, recurrect clear cell ovarian cancer. I guess what I have discovered through my journey is that every one of us is treated individually, what works for one may not work for another. My best to you and your friend. Roni0 -
my experience
I am currently in my 5th year of battling stage 3C OC.Although the dr. at Cleveland Clinic suspected advanced disease, it was my understanding the staging was done once he could see how far the cancer had spread thru surgery and lab testing of tumors and lymph nodes. The debulking reduced everything to a microscopic level. Even though I have had 4 reoccurrences, they have all been small tumors and reacted very well to the varios chemo treatments.Has your friend had a second onc look over records. Maybe it's just me, but I would want surgery a.s.a.p. Good luck to you0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards